Dexmedetomidine withdrawal syndrome and opioid sensitivity

2020 ◽  
pp. bmjspcare-2020-002705
Author(s):  
Lana Ferguson ◽  
Stacey Hooper
Keyword(s):  
Case Report ◽  
Pain Management ◽  
Cancer Pain ◽  
Withdrawal Syndrome ◽  
Urothelial Cancer ◽  
Cancer Pain Management ◽  
Metastatic Urothelial Cancer ◽  
Opioid Sensitivity

This case report describes the use of dexmedetomidine for refractory cancer pain management in a patient with significant pelvic disease due to metastatic urothelial cancer. Specifically, the management of increased opioid sensitivity secondary to dexmedetomidine is discussed. Further, the phenomenon of dexmedetomidine withdrawal syndrome and our management of this is addressed.

scholarly journals CANCER PAIN MANAGEMENT: ROLE OF INTRATHECAL ALCOHOL: A CASE REPORT

2015 ◽  
Vol 04 (14) ◽  
pp. 2418-2421
Author(s):  
Upendra Singh K ◽  
Kh. Lokeshwar Singh ◽  
Thoibahenba Singh S ◽  
Charan N ◽  
Jonan Puni Kay
Keyword(s):  
Case Report ◽  
Pain Management ◽  
Cancer Pain ◽  
Cancer Pain Management

scholarly journals From Cancer Treatment to Cancer Survivorship: A Case Report Demonstrating the Dynamic Roles of Intrathecal Drug Delivery System in Various Phases of Cancer Care

2020 ◽  
pp. 131-134
Author(s):  
Po-Yi Paul Su
Keyword(s):  
Drug Delivery ◽  
Case Report ◽  
Pain Management ◽  
Cancer Pain ◽  
Drug Delivery System ◽  
Cancer Care ◽  
Drug Delivery Systems ◽  
Opioid Therapy ◽  
Cancer Pain Management ◽  
Intrathecal Drug Delivery

Background: Until the continued improvements in cancer diagnosis and treatment, many cancers were once considered terminal illnesses. Opioid-based therapy is frequently utilized from the armamentarium for cancer pain treatment since the immediate goals of acute cancer pain management are focused on alleviating pain severity and improving quality of life during this limited time – despite the risks of chronic opioid therapy. However, now, with an expanding cancer survivor population, we lack guidance and tools to assist health care providers and patients in pivoting the focus of cancer pain management from acute relief toward improving function, rehabilitation, and limiting the long-term adverse effects of pain and opioid therapy. Case Report: Here, we present a case exemplifying the ability of intrathecal drug delivery systems to serve a multitude of roles during the various phases of cancer care: from treating acute cancer-related pain, acting as a tool to wean systemic opioid therapy, to being clinically dormant in situ but ready to serve again in the event of cancer recurrence. Conclusion: Intrthecal drug delivery systems are effective tools in managing acute cancer pain and can also be adapted to help manage chronic pain in cancer survivors. Key words: Cancer pain, intrathecal drug delivery system, intrathecal pump, opioid weaning

Use of Epidural Steroid as an Adjuvant in Neuropathic Cancer Pain Management: A Case Report

2010 ◽  
Vol 27 (7) ◽  
pp. 482-485 ◽  
Author(s):  
Seema Mishra ◽  
Shiv Pratap Singh Rana ◽  
Surjya Prasad Upadhyay ◽  
Sushma Bhatnagar
Keyword(s):  
Case Report ◽  
Pain Management ◽  
Cancer Pain ◽  
Cancer Pain Management ◽  
Epidural Steroid

Cancer pain management

2014 ◽  
Vol 155 (3) ◽  
pp. 93-99
Author(s):  
Péter Heigl
Keyword(s):  
Quality Of Life ◽  
Pain Management ◽  
Pain Relief ◽  
Life Expectancy ◽  
Cancer Pain ◽  
Cancer Pain Management ◽  
Medical Activity ◽  
Short Summary ◽  
Adequate Quality

Pain is a significant and alarming symptom of cancer seriously affecting the activity and quality of life of patients. Recent research proved that inadequate analgesia shortens life expectancy. Therefore, pain relief is not only a possibility but a professional, ethical and moral commitment to relieve patients from suffering, as well as ensure their adequate quality of life and human dignity. Proper pain relief can be achieved with medical therapy in most of the cases and the pharmacological alternatives are available in Hungary. Yet medical activity regarding pain relief is far from the desired. This paper gives a short summary of the guidelines on medical pain management focusing particularly on the use of opioids. Orv. Hetil., 2014, 155(3), 93–99.

Sign in / Sign up

Export Citation Format

Share Document